Skip to main content
SpringerLink
Log in

Is the efficacy of epoetin beta in anemic peritoneal dialysis patients maintained with fortnightly doses?

  • Practice Point
  • Published:

From Nature Clinical Practice Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Locatelli F et al. (2002) Once-weekly compared with three-times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study. Am J Kidney Dis 40: 119–125

    Article  CAS  Google Scholar 

  2. Weiss LG et al. (2000) The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group. Nephrol Dial Transplant 15: 2014–2019

    Article  CAS  Google Scholar 

  3. Beshara S et al. (2004) Varying intervals of subcutaneous epoetin alfa in hemodialysis patients. J Nephrol 17: 525–530

    CAS  PubMed  Google Scholar 

  4. Locatelli F et al. (2004) Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19 (Suppl 2): ii1–ii47

    PubMed  Google Scholar 

  5. Tolman C et al. (2005) Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical study. J Am Soc Nephrol 16: 1463–1470

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Senior Physician in the Department of Renal Medicine at Karolinska University Hospital Huddinge, Stockholm, Sweden

    Peter Bárány

Authors
  1. Peter Bárány
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Bárány.

Ethics declarations

Competing interests

Peter Bárány has participated in working groups for the European Best Practice Guidelines and national guidelines for the management of anemia in patients with chronic renal failure. He has received honoraria and reimbursement for lectures, participation in symposia, workshops and educational activities from Roche, Janssen-Cilag and Amgen, and been involved in clinical trials sponsored by these companies. He has also received honoraria for membership of scientific advisory boards for Amgen and Vifor, and has written expert reports for Baxter and Nebo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bárány, P. Is the efficacy of epoetin beta in anemic peritoneal dialysis patients maintained with fortnightly doses?. Nat Rev Nephrol 1, 12–13 (2005). https://doi.org/10.1038/ncpneph0022

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0022

  • Springer Nature Limited

Search

Navigation